The federal government has been—and must remain—a critical partner in foundational technological innovation and research ...

These upcoming presentations underscore the breadth and versatility of our ACT-UP1 platform,” said Xuehai Liang, Ph.D., Chief Executive Officer of Arnatar Therapeutics. “By demonstrating the ability ...

In vivo studies demonstrate robust and durable gene silencing across rodents and non-human primates Megalin-targeting ligand-siRNA conjugates ...

A defined, xeno-free culture medium from Takara Bio Europe is opening new possibilities for large-scale production of ...

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...

Researchers identify FGFR4, FLT1, and WNT5A as key biomarkers and suggest dovitinib and nintedanib as new targeted therapies ...

The Korea National Institute of Health, under the Korea Disease Control and Prevention Agency, announced on the 17th that it ...

Alternative splicing exhibits lineage-specific variability, with mammals and birds reaching the highest levels despite conserved intron-rich architectures, while unicellular eukaryotes and prokaryotes ...

Under the terms of the deal, Gilead will put down $120 million in an upfront payment and will promise up to $1.52 billion in ...

"The longevity gene (LAV-BPIFB4) is the first candidate gene capable of rejuvenating a heart damaged by progeria," added ...